SE-ALTUVOCT®

Move towards Normalised haemostasis with FVIII

Altuvoct Summary
References

FVIII, factor VIII; NH, normalisation of haemostasis; PwHA, people living with haemophilia A; SHL, standard half-life

  1. Chowdary P et al. TH Open 2025;9:a26219749
  2. De la Corte-Rodriguez H et al. Haemophilia 2022;28:138–44;
  3. Levy-Mendelovich S et al. J Clin Med 2021;10:4303–12;
  4. Oka G et al. Haemophilia 2023;29:709–15;
  5. Wilkins RA et al. BMJ Open 2022;12:e052358;
  6. Pinto PR et al. Pain Med 2020;21:458–71;
  7. Holme PA et al. Haemophilia 2024;30:1109–14;
  8. von Drygalski A et al. N Engl J Med 2023;388:310–8;  
  9. Malec L et al. N Engl J Med 2024;391:235–46;
  10. ALTUVOCT® SmPC, 2026
PP-34699
Other sites
expand_less